文献速递系统性红斑狼疮血管炎

系统性红斑狼疮患者内皮功能障碍与I型干扰素系统及血小板活化相关

Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus.
PubMed 文献 · RMD Open · 2017-10-25

研究纳入148例系统性红斑狼疮(SLE)患者与79例性别年龄匹配的健康对照,评估I型干扰素活性、内皮功能障碍替代标志物(sVCAM-1、内皮微粒)及反应性充血指数(RHI)与血小板活化的关系。SLE患者中I型干扰素活性与高sVCAM-1(OR 1.68,p<0.01)及内皮微粒升高(OR 1.40,p=0.03)相关;高I型干扰素活性患者RHI低于健康对照(OR 2.61,p=0.04);内皮功能障碍患者可见补体沉积于血小板,高sVCAM-1与C4d(OR 4.57,p<0.01)及C1q(OR 4.10,p=0.04)沉积增加相关,高内皮微粒与C4d沉积相关(OR 3.64,p=0.03)。作者认为I型干扰素系统、受损内皮与活化血小板之间的相互作用可能促进SLE心血管疾病发生。

要点

  • SLE患者中I型干扰素活性与内皮活化标志物sVCAM-1升高(OR 1.68,p<0.01)及内皮微粒升高(OR 1.40,p=0.03)相关。
  • 高I型干扰素活性的SLE患者RHI低于健康对照(OR 2.61,p=0.04),提示内皮功能障碍。
  • 内皮功能障碍的SLE患者存在血小板补体沉积,高sVCAM-1与血小板C4d(OR 4.57,p<0.01)及C1q(OR 4.10,p=0.04)沉积增加相关。

核心结论

  • 内皮功能障碍与血小板活化及I型干扰素系统激活相关。
  • 作者认为I型干扰素系统、受损内皮与活化血小板之间的相互作用可能促进SLE中心血管疾病的发生。

研究设计与样本

  • 研究纳入148例SLE患者和79例性别匹配、年龄匹配的健康对照。
  • I型干扰素活性采用报告细胞试验评估,血小板活化采用流式细胞术评估。
  • 内皮功能障碍采用内皮活化替代标志物可溶性血管细胞黏附分子-1(sVCAM-1)和内皮微粒(EMPs)评估,并用手指体积描记法测定反应性充血指数(RHI)。

主要发现

  • SLE患者中I型干扰素活性与高sVCAM-1相关(OR 1.68,p<0.01),与内皮微粒升高相关(OR 1.40,p=0.03)。
  • 高I型干扰素活性的SLE患者RHI低于健康对照(OR 2.61,p=0.04),提示内皮功能障碍。
  • 内皮功能障碍的SLE患者可见补体因子沉积于血小板,作为血小板活化的指标。
  • 高sVCAM-1水平与血小板C4d沉积增加相关(OR 4.57,p<0.01),与C1q沉积增加相关(OR 4.10,p=0.04)。
  • 高内皮微粒水平与血小板C4d沉积相关(OR 3.64,p=0.03)。

关键数值与推荐

  • SLE患者中高sVCAM-1与I型干扰素活性的OR为1.68(p<0.01)。
  • SLE患者中内皮微粒升高与I型干扰素活性的OR为1.40(p=0.03)。
  • 高I型干扰素活性SLE患者RHI低于健康对照的OR为2.61(p=0.04)。
  • 高sVCAM-1与血小板C4d沉积的OR为4.57(p<0.01),与血小板C1q沉积的OR为4.10(p=0.04)。
  • 高内皮微粒与血小板C4d沉积的OR为3.64(p=0.03)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Endothelial dysfunction may be connected to cardiovascular disease (CVD) in systemic lupus erythematosus (SLE). Type I interferons (IFNs) are central in SLE pathogenesis and are suggested to induce both endothelial dysfunction and platelet activation. In this study, we investigated the interplay between endothelial dysfunction, platelets and type I IFN in SLE. METHODS: We enrolled 148 patients with SLE and 79 sex-matched and age-matched healthy controls (HCs). Type I IFN activity was assessed with a reporter cell assay and platelet activation by flow cytometry. Endothelial dysfunction was assessed using surrogate markers of endothelial activation, soluble vascular cell adhesion molecule-1 (sVCAM-1) and endothelial microparticles (EMPs), and finger plethysmograph to determine Reactive Hyperaemia Index (RHI). RESULTS: In patients with SLE, type I IFN activity was associated with endothelial activation, measured by high sVCAM-1 (OR 1.68, p<0.01) and elevated EMPs (OR 1.40, p=0.03). Patients with SLE with high type I IFN activity had lower RHI than HCs (OR 2.61, p=0.04), indicating endothelial dysfunction.Deposition of complement factors on platelets, a measure of platelet activation, was seen in patients with endothelial dysfunction. High levels of sVCAM-1 were associated with increased deposition of C4d (OR 4.57, p<0.01) and C1q (OR 4.10, p=0.04) on platelets. High levels of EMPs were associated with C4d deposition on platelets (OR 3.64, p=0.03). CONCLUSIONS: Endothelial dysfunction was associated with activation of platelets and the type I IFN system. We suggest that an interplay between the type I IFN system, injured endothelium and activated platelets may contribute to development of CVD in SLE.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Tydén H, Lood C, Gullstrand B, et al. Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus. RMD Open. 2017. PMID: 29119007. doi:10.1136/rmdopen-2017-000508

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。